These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37161267)

  • 1. Drug transfer during intimate moments: A key issue in doping control that can be documented by hair tests of the athlete and the partner.
    Kintz P
    Med Sci Law; 2024 Jan; 64(1):72-76. PubMed ID: 37161267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authorities.
    Kintz P; Gheddar L
    Clin Chim Acta; 2024 Jun; 559():119688. PubMed ID: 38670521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of ostarine excretion in oral fluid after a single controlled oral administration.
    Kintz P; Gheddar L; Garnier D
    Clin Chim Acta; 2024 Apr; 557():117879. PubMed ID: 38499138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
    Alvarez JC; Etting I; Larabi IA
    Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-intentional doping in sports.
    Yonamine M; Garcia PR; de Moraes Moreau RL
    Sports Med; 2004; 34(11):697-704. PubMed ID: 15456345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. True Dopers or Negligent Athletes? An Analysis of Anti-Doping Rule Violations Reported to the World Anti-Doping Agency 2010-2012.
    de Hon O; van Bottenburg M
    Subst Use Misuse; 2017 Dec; 52(14):1932-1936. PubMed ID: 28742405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative medicine and doping in sports.
    Koh B; Freeman L; Zaslawski C
    Australas Med J; 2012; 5(1):18-25. PubMed ID: 22905051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of emerging patterns of drug misuse in sports via wastewater monitoring: A mini-review and potential strategies.
    Chang WC; Hsu MC; Liao PC
    Environ Pollut; 2023 Sep; 333():122087. PubMed ID: 37348696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plea for thresholds, i.e., maximal allowed levels for prohibited substances, to prevent questionable doping convictions.
    Burke MG; Faber K
    Sci Justice; 2012 Sep; 52(3):199-201. PubMed ID: 22841145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually transmitted doping: The impact of urine contamination of semen.
    Handelsman DJ; Bacha F; DeBono M; Sleiman S; Janu MR
    Drug Test Anal; 2022 Sep; 14(9):1623-1628. PubMed ID: 35655428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the biological passport: the experience of the International Cycling Union.
    Zorzoli M; Rossi F
    Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
    Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
    Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the athlete's claim of an unintentional positive urine drug test.
    Anderson JM
    Curr Sports Med Rep; 2011 Jul; 10(4):191-6. PubMed ID: 23531893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
    Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
    J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.